Tamoxifen for the prevention of breast cancer: Psychosocial impact on women participating in two randomized controlled trials

Journal of Clinical Oncology

Volumn 19, Issue 7, 2001, Pages 1885-1892

  Fallowfield, L ^a   Fleissig, A ^a   Edwards, R ^a   West, A ^a   Powles, T J ^a   Howell, A ^a   Cuzick, J ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ANXIETY; ARTHRALGIA; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTRESS SYNDROME; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENERGY; FEMALE; FOLLOW UP; HEADACHE; HOT FLUSH; HUMAN; MAJOR CLINICAL STUDY; MOOD; MUSCLE STIFFNESS; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SELF REPORT; SEXUAL FUNCTION; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; VASOMOTOR REFLEX; VISUAL IMPAIRMENT;

EID: 0035300748     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.7.1885     Document Type: Article

References (24)

1. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
2. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
3. Prevention of breast cancer with tamoxifen: Preliminary findings from the Italian randomised trial among hysterectomised women
4. Effect of early American results on patients in a tamoxifen prevention trial (IBIS). International Breast Cancer Intervention Study
5. Tamoxifen and contralateral breast cancer
6. Prevention of breast cancer with tamoxifen: An update on the Royal Marsden Hospital pilot programme
7. Symptoms associated with tamoxifen treatment in postmenopausal women
8. Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial
9. Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 study
10. Chemoprevention of breast cancer with tamoxifen
11. What are the psychological factors influencing attendance, non-attendance and re-attendance at a breast screening centre?
12. Development of the Multidimensional Health Locus of Control (MHLC) Scales
13. The sexual activity questionnaire: A measure of women's sexual functioning
14. Sexual activity questionnaires in clinical trials: Acceptability to patients with gynaecological disorders
15. Living with advanced breast cancer: Development and application of a clinical checklist for patients on endocrine therapy
16. Anxiety in women 'at risk' of developing breast cancer
17. Incomplete quality of life data in randomized trials: Missing forms
18. Tamoxifen in healthy premenopausal and postmenopausal women: Different risks and benefits
19. The magnitude of compliance and non-compliance
20. Symptom reporting in cancer patients. The role of negative affect and experienced social stigma
21. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: Validation of an endocrine symptom subscale for the Fact-B